The UK’s decision to leave the European Union will have a significant impact on life science companies in Europe. Companies need to start preparing now to ensure that disruption to their business is minimised once Brexit happens. We can help. In these Brexit Case Studies we look at how we helped two companies better prepare for this seismic geo-political event. Acorn Regulatory is the only regulatory affairs consultancy in Europe with a dedicated Brexit department. Our team of specialists are working with companies across Europe on issues such as regulatory strategy, EU QPPV requirements, EU Authorised Representative services and more. Since June 2016 our Brexit specialists have been assisting board members, senior management and regulatory departments at a diverse range of companies. All of these companies have engaged Acorn Regulatory to help them to navigate through the most tumultuous political decision to impact on the business sector in over half a century. Our Brexit department draws upon the resources of our expert pharmaceutical, pharmacovigilance, clinical trials and medical device consultants.